Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USSC launches Ray spinal fusion implant following FDA approval Oct. 29.

This article was originally published in The Gray Sheet

Executive Summary

USSC RAY SPINAL FUSION CAGE AVAILABLE IMMEDIATELY following FDA approval Oct. 29 of a premarket approval application for the device. The approval covers use of the device in a range of sizes (12 mm, 14 mm, 16 mm and 18 mm diameters and 21 and 26 mm lengths) for treatment of symptomatic degenerative disk disease (DDD) of the lumbar spine via a posterior surgical approach.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel